Suntou-gun, Japan

Toshiro Ochiai

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyowa Hakko Kirin Co., Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiro Ochiai. Retrieved from https://idiyas.com/inventor/toshiro-ochiai-7h3pc6me

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Toshiro Ochiai

Introduction

Toshiro Ochiai is a notable inventor from Sunto-gun, Japan, recognized for his contributions to pharmaceuticals through innovative developments in microcrystal technology. He holds a patent that exemplifies his expertise in enhancing drug formulation, ultimately aiming to improve therapeutic outcomes.

Latest Patents

Ochiai's singular patent describes the creation of microcrystals of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione. These microcrystals exhibit an average particle size of less than 50 micrometers and boast a crystallinity of 20% or more. His invention delivers excellent solubility, stability, bioavailability, and dispersing properties, making it a valuable addition to pharmaceutical formulations. The patent highlights the potential of these microcrystals to elevate the effectiveness of drug delivery systems.

Career Highlights

Toshiro Ochiai has made significant strides in the pharmaceutical industry, particularly through his role at Kyowa Hakko Kirin Co., Limited. His work has focused on advancements in drug formulation and development, contributing to the evolving landscape of pharmaceuticals. His patent reflects not just innovative thought but also a deep understanding of the challenges besetting drug solubility and bioavailability.

Collaborations

Throughout his career, Ochiai has collaborated with fellow researchers, including Kazutoshi Kuroda and Noboru Aoki. These collaborations have likely enriched his research endeavors, fostering a collective approach to innovation in pharmaceutical sciences. Working together with skilled professionals in the field has enabled the advancement and practical application of their collective findings.

Conclusion

Toshiro Ochiai's contributions to the world of pharmaceuticals through his innovative patent on microcrystal technology underscore his role as a leading inventor. His work at Kyowa Hakko Kirin Co., Limited, coupled with fruitful collaborations, showcases a commitment to enhancing drug efficacy and accessibility. As the pharmaceutical landscape continues to evolve, inventors like Ochiai play a pivotal role in pushing the boundaries of innovation for improved health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…